Professional Documents
Culture Documents
1
DELIRIUM
• Sindrome
• =Acute confusional state, Sundowning,
Ensephalopaty, dan sindroma otak organik
akut
• Neurocognitive disorder (DSM-5)
• Acute onset fluctuating cognitive impairment
and disturbance of consiousness
• Epidemiology: 0,4 -1,1%
• 10-30% of medically ill patients
2
Diagnostic criteria Delirium (DSM-5)
A. A disturbance in attention (i.e., reduced ability to direct, focus, sustain, and
shift attention) and awareness (reduced orientation to the environment).
B. The disturbance develops over a short period of time (usually hours to a
few days), represents a change from baseline attention and awareness, and
tends to fluctuate in severity during the course of a day.
C. An additional disturbance in cognition (e.g., memory deficit, disorientation,
language, visuospatial ability, or perception).
D. The disturbances in Criteria A and C are not better explained by another
preexisting, established, or evolving neurocognitive disorder and do not
occur in the context of a severely reduced level of arousal, such as coma.
E. There is evidence from the history, physical examination, or laboratory
findings that the disturbance is a direct physiological consequence of
another medical condition, substance intoxication or withdrawal (i.e., due to
a drug of abuse or to a medication), or exposure to a toxin, or is due to
multiple etiologies.
3
Delirium (PPDGJ-III)
• Gangguan kesadaran dan perhatian.
• Gangguan kognitif
– Halusinasi, ilusi, distorsi persepsi
– Disorientasi, ggn daya ingat, berpikir abstrak
• Gangguan psikomotor
• Gangguan siklus tidur-bangun
• Gangguan emosional
• Onset cepat (akut), hilang timbul sepanjang hari
(berfluktuatif), < 6 bulan
4
Karakteristik
• Terjadi akut (jam-hari)
• Kondisi kesadaran fluktuatif , disorientasi
• Berkurangnya kemampuan memusatkan
perhatian
• Agitasi atau somnolen berlebihan
• Emosi labil yang ekstrim
• Dapat terjadi defisit kognitif
5
Tipe delirium
• Hiperaktif
• Hipoaktif
• Mixed
6
Gejala Klinis Delirium
1. Delirium Hipoaktif (29%):
Setidaknya 4 (empat) dari perilaku : penurunan orientasi, penurunan
kesiagaan, bicara yang jarang-jarang atau lambat, letargi, pergerakan
yang melambat, melotot, atau apati.
8
mnemonic
Dementia
Electrolytes
Lungs, liver, heart, kidney, brain
Infection
Rx (especially medications)
Injury, pain, stress
Unfamiliar environment
Metabolic
Inouye SK. Conn Med1993;57:309-15
9
Penyakit sistemik
• Infeksi
• Ketidakseimbangan elektrolit
• Disfungsi endokrin
• Kegagalan hati- ensefalopati hepatikum
• Gagal ginjal- ensefalopati uremikum
• Penyakit paru dengan hipoksemia
• Penyakit jantung : CHF, aritmia, infark
• Patologis SSP: tumor, stroke , kejang
• Defisiensi nutrisi: tiamin, asam folat, B12
10
Obat
– Antikholinergics (difenhidramin), TCAs
( amitriptilin, imipramin), antipsikotik
(chlorpromazine, thioridazine)
– Antiinflamasi , steroid
– Benzodiazepin atau alkohol — toksik akut atau
withdrawal
– Kardiovascular (digitalis, antihipertensif)
– diuretics
– Anti Histamin (cimetidine, ranitidine)
– Lithium
– Opioid (terutama meperidine)
11
Faktor Predisposisi
• > 60 tahun • Depresi
• Laki-laki • Dependensi fungsional
• Gangguan visual • Dehidrasi
• Kelainan SSP stroke, • Ketergantungan/ketagih
tumor, vasculitis, an zat tertentu
trauma, demensia • Fraktur panggul
• Operasi besar yang baru • Abnormalitas metabolik
dijalani • Polifarmasi
12
Faktor Presipitasi
• Obat-obatan • Pembedahan ortopedi
• Penyakit akut berat • Pembedahan jantung
• UTI • ICU admission
• Hiponatremia • Prosedur rumah sakit
• Hipoksemia yang sering
• Syok
• Anemia
• Nyeri
13
Patofisiologi
Acetylcholine
- Preoperative plasma cholinesterase menurun
postoperative delirium
- Teori : Terapi Anticholinergic ACS, pasien dengan
gangguan transmisi ACH (contoh: Alzheimer), lebih
rentan
Dopamine
- Pada delirium, aktivitas dopamin berlebihan terapi
antidopamin
•
14
• Neurotransmiter lain:
- Serotonin: meningkat pada hepatic
encephalopathy dan septic
- Gamma-aminobutyric acid (GABA): hepatic
encephalopathy, inhibitory GABA meningkat
GABA juga menurun pada benzodiazepine dan
alcohol withdrawal.
15
• Cortisol dan beta-endorphins
• Inflamasi: sitokin Il-1, Il-6
• Reaksi stres: psikososial dan kurang tidur
• Mekanisme struktural jalur spesifik tidak
diketahui.
16
Click icon to add picture
17
18
Penilaian Delirium
19
20
Terapi non famakologis
• Yang terpenting atasi penyakit dasar
• Intervensi lingkungan: petunjuk yang
mempermudah orientasi (kalender, jam, foto
keluarga, jendela), mengorientasi pasien
berulang, keluarga dan teman yang
berkunjung memperkenalkan diri mereka,
meminimalisir pergantian shift paramedis
yang bertugas
• Meminimalisir obat psikoaktif
21
Terapi Farmakologis
• Tidak ada obat spesifik yang diindikasikan untuk
mengatasi gejala perilaku
• Haloperidol paling banyak diteliti, efektif untuk
agitasi
• Low dose
– Dosis: 2-3 x 0,5 -1,5 mg i.o
– Injeksi 2,5 – 5 mg IM /IV @ 12-24 jam
• Efek samping antikolinergik minimal
• Efek samping kardiovaskuler yang minimal
• prolonged QT intervaL
• Waspada EPS (ektrapyramidal symptom)
22
Atypical Antipsychotic
• Penelitian sama efektifnya dengan haloperidol
• Pilihan IM:
• Olanzapine 2.5 - 5mg IM q 4-6 hours prn maksimal
20mg/hari
• Ziprasidone IM 10mg IM q 6-8 hours prn maksimal
30mg/hari
23
• Mulai dengan prn namun jika sering digunakan, dapat
diberikan rutin:
o Haloperidol 0.5-1 mg i.o - @8-12 jam sampai 10
mg/hari
o Quetiapine 12.5-25 mg i.o - @12jam sampai 150
mg/hari (pilihan utama untuk Parkinson’s atau Lewy
Body)
o Risperidone 0.25-0.5 mg i.o- @8-12 jam sampai 2
mg/hari
o Olanzapine 2.5-5 mg i.o - @12-24 jam sampai 10
mg/hari
24
DEMENTIA
• (DSM-5)
= Major Neurocognitive Disorders
• Progressive impairment of cognitive functions occurring in
clear consciousness.
• Global impairment of intellect is the essential feature,
manifested as difficulty with memory, attention, thinking,
and comprehension.
• Other mental functions can often be affected, including
mood, personality, judgment, and social behavior.
25
Epidemiology
• General population ≥ 65 y.o: 5%
• General population ≥ 85 y.o: 20-40%
• Outpatient general medical practices: 15-20%
• In chronic care facilities: 50%
• Type:
– Alzheimer
– Vascular
– Others (trauma; alkohol; Huntington ds;Parkinson ds;
etc)
26
Cause of Dementia
27
Screening
28
29
Clock drawing test
30
Diagnostic Criteria DSM-5
Major Neurocognitive disorders (Dementia)
A. Evidence of significant cognitive decline from a previous level of
performance in one or more cognitive domains (complex attention,
executive function, learning and memory, language, perceptual-
motor, or social cognition) based on:
1. Concern of the individual, a knowledgeable informant, or the clinician that
there has been a significant decline in cognitive function; and
2. A substantial impairment in cognitive performance, preferably
documented by standardized neuropsychological testing or, in its
absence, another quantified clinical assessment.
B The cognitive deficits interfere with independence in everyday
activities (i.e., at a minimum, requiring assistance with complex
instrumental activities of daily living such as paying bills or managing
medications).
C. The cognitive deficits do not occur exclusively in the context of a
delirium.
D. The cognitive deficits are not better explained by another mental
disorder (e.g., major depressive disorder, schizophrenia).
31
Major Neurocognitive Disorders
(=Dementia)
Specify:
Without behavioral disturbance: If the cognitive disturbance is not
accompanied by any clinically significant behavioral disturbance.
33
CLINICAL FEATURE
Dementia
symptoms
Wandering,
Etc
Non Cognitive
Cognitive (= BPSD)
34
Differential Diagnosis
• Mild Cognitive Impairment
• Delirium
• Depression
• Specific learning disorder and other
neurodevelopmental disorders
• Factitious Disorders
35
36
DEMENTIA Vs DEPRESSION
37
Comorbidity
• Dementia + delirium
• Dementia + neurodevelopmental disorders
38
Treatment
Prinsip penatalaksanaan:
Non-farmakologi lini pertama
Farmakologiderajat sedang-berat, atau tidak memberikan
respon terhadap terapi non-farmakologi
Risks and benefits
39
Non-pharmacological Therapy
• Activity and recreation.
• Aromatherapy, Massage.
• Reminiscence therapy.
• Music therapy.
• Muscle relaxation training.
• Pets.
• Carer education (communication, environmental
modifications, etc)
• Physical restraint
40
Simfoni Kehidupan Manusia
41
42
Pharmacological Therapy
• No proven alternative psychotropic
• Antipsychotic atypical/typical, for psychotic
symptoms, agitation, aggression.
• Antidepressants
• Cognitive Enhancers
• Other Medications
– Anticonvulsants
– Benzodiasepines
43
Treatment Demensia
1.Kognitif
1. 1st class: Cholinesterase inhibitors
Donepezil HCl, galantamine, rivastigmine
2. 2nd class: NMDA Receptor Antagonist
Memantine
3. Others
Ginkgo biloba, NSAID, estrogen efficacy unclear
45
Course and Prognosis
• Variable depending on the etiology
• Insidious except when it is caused by a
cerebrovascular event
• Progressive cognitive decline and progressive
functional impairment
46
THANK YOU 47